Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutaneous Adverse Drug Reactions: How to Identify the Trigger.

Actas dermo-sifiliograficas - 1 Oct 2018

Zambernardi A, Label M

Abstract excerpt

It is estimated that 10% to 15% of medicated patients develop adverse drug reactions (ADR). Despite the high prevalence of ADR, the identification of the trigger drugs remains a medical challenge, mainly in polymedicated patients. Our goal is to update the diagnostic tools to identify enhancer drugs of type B-ADR that compromise the skin and /or mucous membranes, in order to optimize patients' follow-up and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens
Share to Causality
Share to Drug Eruptions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Hypersensitivity

Share to Immunoglobulin E

Share to Lymphocyte Activation

Share to Skin Tests

Share to Tryptases

Source

Identifiers

PMID: 29996988
DOI: 10.1016/j.ad.2018.02.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutaneous Adverse Drug Reactions: How to Identify the Trigger.PMID 29996988Read ↗

[The mechanism, prevention and diagnosis of cutaneous adverse drug reaction].Semantic proximity Read ↗

Severe Cutaneous Adverse Drug Reactions: From Causes to MechanismsSemantic proximity Read ↗

The Immunogenetics of Cutaneous Drug Reactions.Semantic proximity Read ↗

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read ↗

Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Semantic proximity Read ↗

Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.Semantic proximity Read ↗

Drug hypersensitivities: definition, epidemiology and risk factors.Semantic proximity Read ↗

Adverse cutaneous drug eruptions: current understanding.Semantic proximity Read ↗

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.Semantic proximity Read ↗

A Recent Update of Pharmacogenomics in Drug-induced Severe Skin ReactionsSemantic proximity Read ↗

Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.Semantic proximity Read ↗

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.